tiprankstipranks
Trending News
More News >

Jacobson Pharma Announces Final Dividend for FY2025

Story Highlights
Jacobson Pharma Announces Final Dividend for FY2025

Don’t Miss TipRanks’ Half-Year Sale

Jacobson Pharma Corporation Limited ( (HK:2633) ) has issued an update.

Jacobson Pharma Corporation Limited has announced a final ordinary cash dividend of HKD 0.055 per share for the financial year ending March 31, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may enhance its attractiveness to investors, potentially impacting its market positioning positively.

More about Jacobson Pharma Corporation Limited

Jacobson Pharma Corporation Limited operates in the pharmaceutical industry, focusing on the development, production, and distribution of a wide range of generic drugs and over-the-counter products. The company is positioned in the Hong Kong market, catering to healthcare needs with its diverse pharmaceutical offerings.

Average Trading Volume: 880,176

Technical Sentiment Signal: Buy

Current Market Cap: HK$2.57B

Find detailed analytics on 2633 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1